Dr. Zevallos’ clinical interests include the management of head and neck squamous cell carcinoma, salivary gland tumors, thyroid and parathyroid conditions, and benign tumors of the head and neck. He has a special interest in transoral robotic surgery for HPV+ oropharyngeal squamous cell carcinoma. He also has a strong interest in head and neck cancer epidemiology and population sciences.

Dr. Zevallos has published over 120 peer-reviewed research articles and is a highly sought-after speaker at national and international conferences on head and neck cancer. He is a member of the International Head and Neck Cancer Epidemiology Consortium, American Head and Neck Society, American Thyroid Association, American Association of Clinical Endocrinologists, American Academy of Otolaryngology-Head and Neck Surgery, and the Triological Society. He is a Fellow of the American College of Surgeons. He is on the Editorial Boards of Oral Oncology and Cancer Medicine, and an Associate Editor of Head & Neck.

Dr. Zevallos is also the founder and chair of the board of a molecular diagnostics start-up company, Droplet Biosciences, based in Cambridge, MA. Droplet Biosciences developed LymphDetect™ Head & Neck, a CLIA test that identifies head and neck cancer recurrence with unprecedented immediacy and sensitivity. He continues to be actively engaged in entrepreneurship and the development of responsible academic-industry collaborations across otolaryngology.